Format

Send to

Choose Destination
Nat Med. 2018 Jul;24(7):904-906. doi: 10.1038/s41591-018-0114-7.

Predicting progression to AML.

Author information

1
Brigham and Women's Hospital, Boston, MA, USA.
2
Broad Institute of MIT and Harvard, Cambridge, MA, USA.
3
UCL Cancer Institute, University College London, London, UK.
4
Department of Pathology, Stanford University, Stanford, CA, USA.
5
Brigham and Women's Hospital, Boston, MA, USA. bebert@partners.org.
6
Broad Institute of MIT and Harvard, Cambridge, MA, USA. bebert@partners.org.
7
Dana-Farber Cancer Institute, Boston, MA, USA. bebert@partners.org.
PMID:
29988142
DOI:
10.1038/s41591-018-0114-7
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center